India Glycols Shares Rise 5% as Stock Adjusts for Three-Way Demerger
Key Takeaways
- •India Glycols shares rose as much as 5% after the stock began trading on an adjusted basis following its demerger into three entities.
- •The restructuring separates the company into the listed chemicals business (India Glycols Ltd), IGL Spirits Ltd for alcoholic beverages, and Ennature Bio Pharma Ltd for biopharma operations.
- •Shareholders will receive shares in the newly created entities according to the prescribed entitlement ratio while retaining their holding in the existing listed chemicals company.
- •The demerger is intended to give each business vertical clearer operational and capital-allocation focus and enable independent valuation by investors.
- •The newly formed entities still require separate approvals and listing processes before their shares can begin trading on the exchanges.
Shares of India Glycols Ltd rose as much as 5% after the stock began trading on an adjusted basis following the company's demerger into three separate entities.
Under the restructuring, the existing India Glycols entity will continue as the listed chemicals business, while the spirits and biopharma operations will be housed under two separate entities — IGL Spirits Ltd and Ennature Bio Pharma Ltd. Demergers of this kind are typically undertaken to give each business vertical clearer operational and capital-allocation focus, and to allow investors to value the separate businesses independently. The move also places India Glycols among a broader set of Indian conglomerates that have split diversified operations into focused listed entities in recent years.
Three businesses under separate entities
The demerger splits the company's operations into three focused businesses:
- India Glycols Ltd — the existing listed entity, which retains the chemicals business.
- IGL Spirits Ltd — the newly formed entity housing the spirits (alcoholic beverages) business.
- Ennature Bio Pharma Ltd — the newly formed entity housing the biopharma business.
India Glycols is a diversified company known for producing green chemistry-based chemicals, including glycols and ethylene oxide derivatives, manufactured largely from renewable agro-based feedstocks. The spirits business operates in the alcoholic beverages segment, while the biopharma arm covers pharmaceutical-related operations, giving each demerged entity a distinct industry profile.
Share entitlement
Under the scheme of arrangement, shareholders of India Glycols receive shares in the newly created entities in accordance with the prescribed share entitlement ratio, in addition to their continued holding in the existing listed chemicals company.
When a demerger takes effect, exchanges typically adjust the stock's price to reflect the value of the businesses being separated, allowing the shares to trade on an ex-demerger basis. Following such adjustments, the newly created entities generally require separate approvals and listing processes before their shares begin trading on the exchanges — a timeline investors typically watch after a demerger becomes effective.
The development marks a significant corporate restructuring for India Glycols, formally separating its chemicals, spirits, and biopharma verticals into independent companies.
Source: CNBC-TV18
